STOCK TITAN

HealWELL AI (HWAIF) Stock News

HWAIF OTC

Welcome to our dedicated page for HealWELL AI news (Ticker: HWAIF), a resource for investors and traders seeking the latest updates and insights on HealWELL AI stock.

HEALWELL AI Inc. develops and commercializes healthcare artificial intelligence software for preventative care, with a focus on clinical decision support, early disease identification, and workflow tools for healthcare providers. News about HWAIF commonly covers the company’s DARWEN™ AI platform, Smart Search, Smart Summary, Smart ID, and the use of AI-enriched clinical data to support real-world evidence across disease areas.

Company updates also include revenue and Adjusted EBITDA reporting, integration of Orion Health, enterprise health-system and Health Information Exchange software contracts, customer renewals, scientific publications, conference participation, and board or governance changes. HEALWELL trades on the Toronto Stock Exchange as AIDX and on the OTCQX market as HWAIF.

Rhea-AI Summary

HEALWELL (OTCQX:HWAIF) will participate in three investor conferences in March 2026: TD Cowen (Boston, Mar 2-4), Scotiabank TMT (Toronto, Mar 3-4) and ROTH (Dana Point, Mar 22-24).

Dr. Alexander Dobranowski will present and hold investor meetings, including a TD Cowen presentation on Mar 3 and a ROTH panel on Mar 23 titled Technologies Advancing Healthy Aging.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
8.04%
Tags
none
-
Rhea-AI Summary

HEALWELL AI (OTCQX:HWAIF) announced its first contracted AI deployment in the Middle East and expanded active deployments across Canada and the United States on February 26, 2026. The Company is deploying SMART Identify, SMART Search, and SMART Summary in multiple healthcare systems, marking cross‑border commercial momentum and platform scalability.

HEALWELL says deployments span frontline care environments and that contracted revenue now exists across Canada, the U.S., and the Middle East, while the company reports a growing pipeline for broader enterprise expansion.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
11.7%
Tags
AI
-
Rhea-AI Summary

HEALWELL AI (OTCQX: HWAIF) and WELL Health launched WELLTRUST™ on February 19, 2026, a consent-first data governance and patient-identification platform deployed across WELL-operated clinics in Canada. WELLTRUST uses patient-controlled consent and HEALWELL's DARWEN™ AI to identify high-fit patients for clinical trials while preserving privacy and compliance.

The platform supports contact consent, unified privacy controls, AI-enabled recruitment, and a governance layer to meet Canadian regulatory standards.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.82%
Tags
Rhea-AI Summary

HEALWELL AI (OTCQX: HWAIF) provided a corporate update on February 12, 2026, outlining platform integration, product rollouts and portfolio simplification.

The company unified Khure and Pentavere into a DARWEN-powered AI engine, plans a North American Amadeus AI launch in 1H-26 (international late 2026), reports early commercial traction via Orion-Verosource initiatives, notes four Q4-2025 publications, and is assessing a USD $2M strategic investment vehicle holding an interest in xAI/SpaceX.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.69%
Tags
AI
-
Rhea-AI Summary

HEALWELL AI (OTCQX: HWAIF) provided additional disclosure after an OSC request to clarify forward-looking statements tied to its November 3, 2025 strategic divestments.

Key factual points: continuing-operations revenue of $30.4M in Q3-2025 (annualized ≈ $120M), a Q3-2025 Adjusted EBITDA of $0.7M versus an Adjusted EBITDA loss of $2.8M in Q3-2024, and a net loss from continuing operations of $16M in Q3-2025. The company completed sales of two non-core businesses and contributed two others to a clinical research joint venture following the Orion Health acquisition (effective April 1, 2025).

The company emphasized assumptions and risks underlying its revenue run-rate and AI capability claims and referenced peer-reviewed validations and industry awards for its DARWEN platform.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.27%
Tags
AI
-
Rhea-AI Summary

HEALWELL AI (OTCQX: HWAIF) appointed Ian Kidson to its Board of Directors, effective December 10, 2025.

Kidson brings decades of financial, governance, and healthcare-related corporate leadership across public and private companies in Canada and the U.S., including roles as CFO at Docebo (2019–2021), CFO and CEO at Apollo Health Corp., EVP & CFO at Progressive Waste Solutions (before its 2016 merger with Waste Connections), and senior capital markets positions at CIBC Wood Gundy and TD Capital Mezzanine Partners. HEALWELL said his financial expertise and experience guiding organizations through growth will support its focus on early identification and detection of disease.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.67%
Tags
management AI
Rhea-AI Summary

HEALWELL (OTCQX: HWAIF) reported Q3-2025 revenue of $30.4M, a 354% increase year‑over‑year driven largely by the Orion Health acquisition. Subscription, support and maintenance revenue rose to $21.0M (+535%). The company posted positive Adjusted EBITDA of $0.7M versus a loss of $2.8M in Q3‑2024, its second consecutive quarter of positive adjusted EBITDA. IFRS net loss from continuing operations was $16.0M (up 83% YoY). HEALWELL exercised its call option to acquire the remaining 49% of Pentavere and launched AmadeusAI integrating DARWEN™. Subsequent divestments and transactions strengthened the balance sheet with approximately $9.7M in cash proceeds, positioning the company as a pure‑play AI, SaaS and services healthcare provider.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.58%
Tags
AI
-
Rhea-AI Summary

HEALWELL AI (OTCQX: HWAIF) completed related‑party transactions with WELL affiliates to become a pure‑play SaaS, services and AI company focused on enterprise healthcare. The Transactions closed Nov 1, 2025, and include: sale of Polyclinic clinics for $1.2M cash plus up to $1.2M earn‑out; sale of HEALWELL's 58.66% Mutuo interest for $8,212,400 (with $615,930 four‑month holdback); and a 50/50 clinical research JV funded with $3.0M contributed by each party and an initial $500k capital call. HEALWELL reports a ~$120M revenue run rate and Adjusted EBITDA profitability, and received approximately $9.4M cash on closing.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.99%
Tags
AI
-
Rhea-AI Summary

HEALWELL AI (OTCQX: HWAIF) and subsidiary Orion Health signed a Memorandum of Understanding with Lean Business Services to explore development and commercialization of AI-driven digital health across the Middle East and Orion's global markets.

The MoU, signed on October 28, 2025 at the Global Health Exhibition in Riyadh, targets AI population health, clinical AI, and data interoperability, including integration with Saudi Arabia's NPHIES platform. Orion Health's regional footprint includes Malaffi (connecting 3,000 facilities, 13 million patients) and a Saudi HIE linking over 5,000 providers and serving > 30 million people.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.92%
Tags
AI
Rhea-AI Summary

HEALWELL AI (OTCQX: HWAIF, TSX: AIDX) will release Fiscal Third Quarter 2025 results for the period ended September 30, 2025 on Thursday, November 6, 2025. The company will host a conference call and simultaneous webcast to discuss results on Friday, November 7, 2025 at 8:30 AM ET / 5:30 AM PT.

The call will be hosted by James Lee (CEO), Dr. Alexander Dobranowski (President) and Anthony Lam (CFO). Webcast access and dial-in details are provided for North American and international participants.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.47%
Tags

FAQ

What is the current stock price of HealWELL AI (HWAIF)?

The current stock price of HealWELL AI (HWAIF) is $0.4799 as of July 27, 2026.

What is the market cap of HealWELL AI (HWAIF)?

The market cap of HealWELL AI (HWAIF) is approximately 160.0M.